Form 4 for CRMD CorMedix Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-12 · accession 0000899140-24-001355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-16 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | — | +12.5K | 62.5K | +25% | — |
| D | 2024-12-16 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.77 | -6,044 | 56.5K | -10% | -$53.0K |
| D | 2024-12-16 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | $0.00 | -12.5K | 37.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-12 | M | A | 12,500 | — | 62,500 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-12-12 | F | D | 6,044 | $8.77 | 56,456 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-12-12 | M | D | 12,500 | $0.00 | 37,500 | D | — · — to — | 12,500 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |